QPTFF Stock - Quest PharmaTech Inc.
Unlock GoAI Insights for QPTFF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A |
| Gross Margin | N/A | N/A | N/A | N/A | N/A |
| Operating Income | $-817,000 | $-1,316,000 | $-834,000 | $-809,000 | $-1,086,140 |
| Net Income | $-1,801,000 | $-3,018,000 | $-64,888,000 | $-85,039,000 | $190.06M |
| Net Margin | N/A | N/A | N/A | N/A | N/A |
| EPS | $-0.01 | $-0.02 | $-0.39 | $-0.51 | $1.13 |
Quest PharmaTech Inc., a pharmaceutical company, develops antibody based immunotherapeutic products for cancer. Its lead product candidate is Mab AR 9.6 against truncated O-glycan on MUC16, for targeted cancer therapy applications. The company also offers Oregovomab, an anti-CA-125 antibody, which has completed Phase II clinical trial for the treatment of ovarian cancer. In addition, it develops, manufactures, and commercializes immunotherapy products for pancreatic cancer. Further, the company develops products by using proprietary transdermal delivery technologies for dermatology and wound healing applications; skin penetrating active molecules for cosmetic and pharmaceutical use; and combinatorial immunotherapeutic products for the treatment cancer by using monoclonal antibodies of the immunoglobulin of G and E class. Quest PharmaTech Inc. is headquartered in Edmonton, Canada.
Visit WebsiteEarnings History & Surprises
QPTFFEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 26, 2026 | — | — | — | — |
Q4 2025 | Dec 23, 2025 | — | — | — | — |
Q3 2025 | Sep 29, 2025 | — | $-0.00 | — | — |
Q2 2025 | Jun 26, 2025 | — | $0.00 | — | — |
Q2 2025 | May 28, 2025 | — | $0.01 | — | — |
Q4 2024 | Dec 23, 2024 | — | $0.00 | — | — |
Q3 2024 | Sep 23, 2024 | — | $0.00 | — | — |
Q2 2024 | Jun 28, 2024 | — | $-0.01 | — | — |
Q2 2024 | May 29, 2024 | — | $0.09 | — | — |
Q4 2023 | Dec 13, 2023 | — | $-0.01 | — | — |
Q3 2023 | Sep 21, 2023 | — | $-0.06 | — | — |
Q2 2023 | Jun 29, 2023 | — | $-0.00 | — | — |
Q2 2023 | May 31, 2023 | — | $-0.37 | — | — |
Q4 2022 | Oct 31, 2022 | — | $-0.01 | — | — |
Q3 2022 | Sep 26, 2022 | — | — | — | — |
Latest News
Frequently Asked Questions about QPTFF
What is QPTFF's current stock price?
What is the analyst price target for QPTFF?
What sector is Quest PharmaTech Inc. in?
What is QPTFF's market cap?
Does QPTFF pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to QPTFF for comparison